$12.350
-0.378 (-3.06%)Zum Schluss
AMWL-News
AMWL-Events
Company Raises 2026 Revenue Outlook to $203.15M
Consensus $203.15M. Narrows FY26 adjusted EBITDA loss view to $7M-$8M from $7M-$9M. Backs FY26 AMG visits view $1.32M-1.37M. The company said, "The Company is raising its 2026 revenue outlook, and adjusted EBITDA outlook, and reaffirming its AMG visit guidance."
Amwell Reports Q3 Revenue of $48.99M, Beating Expectations
Reports Q3 revenue $48.99M, consensus $47.29M. "Health plans and employers want engagement, outcomes and proof, and Amwell's single platform is built to deliver all three," said Ido Schoenberg, Chairman and CEO of Amwell. "Across six focus areas that all run on one platform, we are activating more members, simplifying their experience and deepening their relationship with clinicians, giving customers choice without the sprawl, demonstrating outcomes, and using a common data structure to show what works. We expect to generate positive cash flow from operations in the fourth quarter, and we believe we are well positioned to be the trusted platform where AI-powered care runs."
Company Sees Q4 Adjusted EBITDA of $0M-$1M
Sees Q4 adjusted EBITDA $0M-$1M. The company said, "The Company also reiterated its objective to achieve positive cash flow from operations in the fourth quarter of 2026."
Amwell to Deploy Virtual Health Platform for VA
Amwell announced the Department of Veterans Affairs has declared its intent for the company to deploy its virtual health platform within the VA enterprise and help power the modernization of the VA's digital health infrastructure. The VA anticipates the Amwell platform will support a broad range of clinical services, enhance care coordination, and improve access for our Veterans across the VA enterprise.
Amwell Reports Q2 Revenue of $52.05M, Exceeding Expectations
Reports Q2 revenue $52.05M, consensus $49.88M. "The DHA's intent to make Amwell a prime contractor is a powerful endorsement of our platform and our people," said Ido Schoenberg, Chairman and CEO of Amwell. "With subscription revenue now approaching half our total revenue, independently validated behavioral clinical outcomes, no debt, and positive cash flows from operations projected for the fourth quarter this year, we have never been better positioned to lead the era of AI-powered care."
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.